Biopharmaceutics, pharmacokinetics and pharmacodynamics of antituberculosis drugs

Current Medicinal Chemistry

Volumn 15, Issue 8, 2008, Pages 809-825

  Budha, Nageshwar R ^a   Lee, Richard E ^a   Meibohm, Bernd ^a  

^a UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

Author keywords

Antituberculosis drug; Biopharmaceutics; Drugs development; Pharmacodynamics; Pharmacokinetics; Tuberculosis

Indexed keywords

1 (6 BROMO 2 METHOXY 3 QUINOLINYL) 4 DIMETHYLAMINO 2 (1 NAPHTHYL) 1 PHENYL 2 BUTANOL; 6,7 DIHYDRO 2 NITRO 6 (4 TRIFLUOROMETHOXYBENZYLOXY) 5H IMIDAZO[2,1 B][1,3]OXAZINE; AMINOGLYCOSIDE; AMINOSALICYLIC ACID; CIPROFLOXACIN; CYCLOSERINE; CYTOCHROME P450 1A2; CYTOCHROME P450 2C; CYTOCHROME P450 2D6; CYTOCHROME P450 3A; ENOYL ACYL CARRIER PROTEIN REDUCTASE (NADH); ETHAMBUTOL; ETHIONAMIDE; GATIFLOXACIN; ISONIAZID; KANAMYCIN; LINEZOLID; METRONIDAZOLE; MOXIFLOXACIN; NITRO DIHYDROIMIDAZOOXAZOLE DERIVATIVE; OFLOXACIN; OPC 67683; OXAZOLE DERIVATIVE; PYRAZINAMIDE; RIFAMPICIN; RIFAPENTINE; SQ 109; SQ109; STREPTOMYCIN; THIOACETAZONE; TUBERCULOSTATIC AGENT; UNCLASSIFIED DRUG;

ANTIBIOTIC RESISTANCE; ARTHRALGIA; BACTERIAL CELL WALL; BRAIN TOXICITY; CLINICAL TRIAL; DRUG ABSORPTION; DRUG ACETYLATION; DRUG BIOAVAILABILITY; DRUG CLEARANCE; DRUG DISTRIBUTION; DRUG DOSE ESCALATION; DRUG DOSE INCREASE; DRUG ERUPTION; DRUG EXPOSURE; DRUG FEVER; DRUG HALF LIFE; DRUG HYPERSENSITIVITY; DRUG MEGADOSE; DRUG PENETRATION; DRUG PROTEIN BINDING; DRUG SENSITIVITY; DRUG SOLUBILITY; DRUG STRUCTURE; DRUG TARGETING; FIRST PASS EFFECT; FOOD; FOOD DRUG INTERACTION; GASTROINTESTINAL SYMPTOM; GASTROINTESTINAL TOXICITY; GLUCOSE BLOOD LEVEL; HEPATITIS; HUMAN; HYDROPHILICITY; HYPERGLYCEMIA; HYPERURICOSURIA; HYPOGLYCEMIA; INTESTINE MUCOSA PERMEABILITY; LIPOPHILICITY; LIVER TOXICITY; MONOTHERAPY; MULTIDRUG RESISTANCE; MYCOBACTERIUM TUBERCULOSIS; NEPHROTOXICITY; NEURITIS; OTOTOXICITY; PROTEIN FUNCTION; PROTEIN SYNTHESIS; PSYCHOSIS; RASH; REVIEW; SIDE EFFECT; SINGLE DRUG DOSE; SKIN MANIFESTATION; TUBERCULOSIS; URIC ACID BLOOD LEVEL; VISUAL DISORDER;

ANIMALS; ANTITUBERCULAR AGENTS; BIOPHARMACEUTICS; HUMANS; TUBERCULOSIS;

EID: 42049091409     PISSN: 09298673     EISSN: None     Source Type: Journal    
DOI: 10.2174/092986708783955509     Document Type: Review

References (171)

1. World Health Organization. Fact sheet No 104: Tuberculosis, WHO: Geneva 2007.
2. El-Sadr, W. M.; Perlman, D. C.; Denning, E.; Matts, J. P.; Cohn, D. L. Clin. Infect. Dis., 2001, 32, 623-32.
3. U.S. Department of Health and Human Services Center for Disease Control and Prevention. MMWR Morb. Mortal. Wkly. Rep., 2006, 55, 301-5.
4. Wenzel, R. P. N. Engl. J. Med., 2004, 351, 523-6.
5. Spigelmn, M.; Gillespie, S. Lancet, 2006, 367, 945-7.
6. Kerns, E. H. J. Pharm. Sci., 2001, 90, 1838-58.
7. Prentis, R. A.; Lis, Y.; Walker, S. R. Br. J. Clin. Pharmacol., 1988, 25, 387-96.
8. van De Waterbeemd, H.; Smith, D. A.; Beaumont, K.; Walker, D. K. J. Med. Chem., 2001, 44, 1313-33.
9. Veber, D. F.; Johnson, S. R.; Cheng, H. Y.; Smith, B. R.; Ward, K. W.; Kopple, K. D. J. Med. Chem., 2002, 45, 2615-23.
10. Venkatesh, S.; Lipper, R. A. J. Pharm. Sci., 2000, 89, 145-54.
11. Pritchard, J. F.; Jurima-Romet, M.; Reimer, M. L.; Mortimer, E.; Rolfe, B.; Cayen, M. N. Nat. Rev. Drug Discov., 2003, 2, 542-53.
12. Caldwell, G. W.; Ritchie, D. M.; Masucci, J. A.; Hageman, W.; Yan, Z. Curr. Top. Med. Chem., 2001, 1, 353-66.
13. Volker, C.; Brown, J. R. Curr. Drug Targets Infect. Disord., 2002, 2, 279-90.
14. Global Alliance for TB Drug Development. Tuberculosis (Edinb.), 2001, 81 Suppl. 1, 1-52.
15. Solotorovsky, M.; Gregory, F. J.; Ironson, E. J.; Bugie, E. J.; O'Neill, R. C.; Pfister, R., 3rd. Proc. Soc. Exp. Biol. Med., 1952, 79, 563-5.
16. Cole, S. T.; Brosch, R.; Parkhill, J.; Garnier, T.; Churcher, C.; Harris, D.; Gordon, S. V.; Eiglmeier, K.; Gas, S.; Barry, C. E., 3rd; Tekaia, F.; Badcock, K.; Basham, D.; Brown, D.; Chillingworth, T.; Connor, R.; Davies, R.; Devlin, K.; Feltwell, T.; Gentles, S.; Hamlin, N.; Holroyd, S.; Hornsby, T.; Jagels, K.; Krogh, A.; McLean, J.; Moule, S.; Murphy, L.; Oliver, K.; Osborne, J.; Quail, M. A.; Rajandream, M. A.; Rogers, J.; Rutter, S.; Seeger, K.; Skelton, J.; Squares, R.; Squares, S.; Sulston, J. E.; Taylor, K.; Whitehead, S.; Barrell, B. G. Nature, 1998, 393, 537-44.
17. Mdluli, K.; Spigelman, M. Curr. Opin. Pharmacol., 2006, 6, 459-67.
18. Zhang, Y. Annu. Rev. Pharmacol. Toxicol., 2005, 45, 529-64.
19. Zhang, Y.; Post-Martens, K.; Denkin, S. Drug Discov. Today, 2006, 11, 21-7.
20. Zhang, Y.; Amzel, L. M. Curr. Drug Targets, 2002, 3, 131-54.
21. Bloch, K.; Vance, D. Annu. Rev. Biochem., 1977, 46, 263-98.
22. Banerjee, A.; Dubnau, E.; Quemard, A.; Balasubramanian, V.; Um, K. S.; Wilson, T.; Collins, D.; de Lisle, G.; Jacobs, W. R., Jr. Science, 1994, 263, 227-30.
23. Sullivan, T. J.; Truglio, J. J.; Boyne, M. E.; Novichenok, P.; Zhang, X.; Stratton, C. F.; Li, H. J.; Kant, T.; Amin, A.; Johnson, F.; Slayden, R. A.; Kisker, C.; Tonge, P. J. ACSC hem. Biol., 2006, 1, 43-53.
24. Belanger, A. E.; Besra, G. S.; Ford, M. E.; Mikusova, K.; Belisle, J. T.; Brennan, P. J.; Inamine, J. M. Proc. Natl. Acad Sci. USA, 1996, 93, 11919-24.
25. Alderwick, L. J.; Seidel, M.; Sahm, H.; Besra, G. S.; Eggeling, L. J. Biol. Chem., 2006, 281, 15653-61.
26. Kremer, L.; Dover, L. G.; Morehouse, C.; Hitchin, P.; Everett, M.; Morris, H. R.; Dell, A.; Brennan, P. J.; McNeil, M. R.; Flaherty, C.; Duncan, K.; Besra, G. S. J. Biol. Chem., 2001, 276, 26430-40.
27. Pan, F.; Jackson, M.; Ma, Y.; Mcneil, M. J. Bacteriol., 2001, 183, 3991-8.
28. Li, W.; Xin, Y.; McNeil, M. R.; Ma, Y. Biochem. Biophys. Res. Commun., 2006, 342, 170-8.
29. LeMagueres, P.; Im, H.; Ebalunode, J.; Strych, U.; Benedik, M. J.; Briggs, J. M.; Kohn, H.; Krause, K. L. Biochemistry, 2005, 44, 1471-81.
30. Campbell, E. A.; Korzheva, N.; Mustaev, A.; Murakami, K.; Nair, S.; Goldfarb, A.; Darst, S. A. Cell, 2001, 104, 901-12.
31. Aubry, A.; Pan, X. S.; Fisher, L. M.; Jarlier, V.; Cambau, E. Antimicrob. Agents Chemother., 2004, 48, 1281-8.
32. Ginsburg, A. S.; Grosset, J. H.; Bishai, W. R. Lancet Infect. Dis., 2003, 3, 432-42.
33. Spotts, C. R.; Stanier, R. Y. Nature, 1961, 192, 633-7.
34. Cynamon, M. H.; Klemens, S. P.; Sharpe, C. A.; Chase, S. Antimicrob. Agents Chemother., 1999, 43, 1189-91.
35. Rengarajan, J.; Sassetti, C. M.; Naroditskaya, V.; Sloutsky, A.; Bloom, B. R.; Rubin, E. J. Mol. Microbiol., 2004, 53, 275-82.
36. Zhang, Y.; Wade, M. M.; Scorpio, A.; Zhang, H.; Sun, Z. J. Antimicrob. Chemother., 2003, 52, 790-5.
37. Andries, K.; Verhasselt, P.; Guillemont, J.; Gohlmann, H. W.; Neefs, J. M.; Winkler, H.; Van Gestel, J.; Timmerman, P.; Zhu, M.; Lee, E.; Williams, P.; de Chaffoy, D.; Huitric, E.; Hoffner, S.; Cambau, E.; Truffot-Pernot, C.; Lounis, N.; Jarfier, V. Science, 2005, 307, 223-7.
38. Munoz-Elias, E. J.; McKinney, J. D. Nat. Med., 2005, 11, 638-44.
39. Nunn, P.; Kibuga, D.; Gathua, S.; Brindle, R.; Imalingat, A.; Wasunna, K.; Lucas, S.; Gilks, C.; Omwega, M.; Were, J.; McAdam, K. Lancet, 1991, 337, 627-30.
40. Amidon, G. L.; Lennemas, H.; Shah, V. P.; Crison, J. R. Pharm. Res., 1995, 12, 413-20.
41. Lipinski, C. A. J. Pharmacol. Toxicol. Methods, 2000, 44, 235-49.
42. van de Waterbeemd, H. Eur. J. Pharm. Sci., 1998, 7, 1-3.
43. Avdeef, A.; Testa, B. Cell Mol. Life. Sci., 2002, 59, 1681-9.
44. Avdeef, A. Curr. Top. Med. Chem., 2001, 1, 277-351.
45. Kasim, N. A.; Whitehouse, M.; Ramachandran, C.; Bermejo, M.; Lennemas, H.; Hussain, A. S.; Junginger, H. E.; Stavchansky, S. A.; Midha, K. K.; Shah, V. P.; Amidon, G. L. Mol. Pharm., 2004, 1, 85-96.
46. Meibohm, B.; Derendorf, H. Int. J. Clin. Pharmacol. Ther., 1997, 35, 401-13.
47. Guengerich, F. P. Annu. Rev. Pharmacol. Toxicol., 1989, 29, 241-64.
48. Clinical and Laboratory Standards Institute. Approved Standard M7-A7: Methods for Dilution Antimicrobial Susceptibility Test for Bacteria That Grow Aerobically: Wayne, PA 2007.
49. Flynn, J. L. Microbes Infect., 2006, 8, 1179-88.
50. Gupta, U. D.; Katoch, V M. Tuberculosis (Edinb), 2005, 85, 277-93.
51. Boshoff, H. I.; Barry, C. E., 3rd. Nat. Rev. Microbiol., 2005, 3, 70-80.
52. McMurray, D. N.; Collins, F. M.; Darmenberg, A. M., Jr.; Smith, D. W. Curr. Top. Microbiol. Immunol., 1996, 215, 157-79.
53. Gruppo, V.; Johnson, C. M.; Marietta, K. S.; Scherman H.; Zink, E. E.; Crick, D. C.; Adams, L. B.; Orme, I. M.; Lenaerts, A. J. Antimicrob. Agents Chemother, 2006, 50, 1245-50.
54. Woolhiser, L.; Tamayo, M. H.; Wang, B.; Gruppo, V.; Belisle, J. T.; Lenaerts, A. J.; Basaraba, R. J.; Orme, I. M. Infect. Immun., 2007, 75, 2621-5.
55. Lenaerts, A. J.; Hoff, D.; Aly, S.; Ehlers, S.; Andries, K.; Cantarero, L.; Orme, I. M.; Basaraba, R. J. Antimicrob. Agents Chemother., 2007, 51, 3338-45.
56. Flynn, J. L., Capuano, S. V.; Croix, D.; Pawar, S.; Myers, A.; Zinovik, A.; Klein, E. Tuberculosis (Edinb), 2003, 83, 116-8.
57. Capuano, S. V, 3rd; Croix, D. A.; Pawar, S.; Zinovik, A.; Myers, A.; Lin, P. L.; Bissel, S.; Fuhrman, C.; Klein, E.; Flynn, J. L. Infect. Immun., 2003, 71, 5831-44.
58. Zhang, Y.; Heym, B.; Allen, B.; Young, D.; Cole, S. Nature, 1992, 358, 591-3
59. Peloquin, C. A. In Pharmacotherapy: A Pathophysiologic Approach, Dipiro, JT; Talbert, RL; Yee, GC; Matzke, GR; Wells, BG; Posey, LM, eds.; McGraw-Hill: New York, 2002, pp. 1917-1938.
60. Argyrou, A.; Jin, L.; Siconilfi-Baez, L,; Angeletti, R. H.; Blanchard, J. S. Biochemistry, 2006, 45, 13947-53.
61. Winder, F. G.; Collins, P. B. J. Gen. Microbiol., 1970, 63, 41-8.
62. Del Rio-Estrada, C.; Dougherty, H. W. Kirk-Othmer Encyclopedia of Chemical Technology, John Wliey & Sons, Inc 1970.
63. Nagano, K.; Tsukahara, H.; Kinoshita, H.; Tamura, Z. Chem. Pharm. Bull. (Tokyo), 1963, 11, 797-805.
64. Rekker, R: F.; Nauta, W. T. Pharm. Weekbl., 1964, 99, 1157-65.
65. Becker, C.; Dressman, J. B.; Amidon, G. L.; Junginger, H. E.; Kopp, S.; Midha, K. K.; Shah, V. P.; Stavchansky, S.; Barends, D. M. J. Pharm. Sci., 2007, 96, 522-31.
66. Holdiness, M. R. Clin. Pharmacokinet., 1984, 9, 511-44.
67. Peloquin, C. A.; Jaresko, G. S.; Yong, C. L.; Keung, A. C.; Bulpitt, A. E.; Jelliffe, R. W. Antimicrob. Agents Chemother., 1997, 41, 2670-9.
68. Peloquin, C. A. Med. Clin. North Am., 1993, 77, 1253-62.
69. Weber, W. W.; Hein, D. W. Clin. Pharmacokinet., 1979, 4, 401-22.
70. Mitchison, D. A. Tubercle, 1985, 66, 219-25.
71. Telenti, A.; Imboden, P.; Marchesi, F.; Lowrie, D.; Cole, S.; Colston, M. J.; Matter, L.; Schopfer, K.; Bodmer, T. Lancet, 1993, 341, 647-50.
72. Peloquin, C. A.; Namdar, R.; Singleton, M. D.: Nix, D. E. Chest., 1999, 115, 12-8.
73. Furesz, S. Antibiot. Chemother., 1970, 16, 316-51.
74. Seydel, J. K. Antibiot, Chemother., 1970, 16, 380-91.
75. Kenny, M. T.; Strates, B. Drug Metab. Rev., 1981, 12, 159-218.
76. Bachmann, K. A.; Jauregui, L. Xenobiotica, 1993, 23, 307-15.
77. Dilger, K.; Greiner, B.; Fromm, M. F.; Hofmann, U.; Kroemer, H. K.; Eichelbaum, M. Pharmacogenetics, 1999, 9, 551-9.
78. Gallicano, K. D.; Sahai, J.; Shukla, V. K.; Seguin, I.; Pakuts, A.; Kwok, D.; Foster, B. C.; Cameron, D. W. Br. J. Clin. Pharmacol., 1999, 48, 168-79.
79. Greiner, B.; Eichelbaum, M.; Fritz, P.; Kreichgauer, H. P.; von Richter, O.; Zundler, J.; Kroemer, H. K. J. Clin. Invest., 1999, 104, 147-53.
80. Caraco, Y.; Sheller, J.; Wood, A. J. J. Pharmacol. Exp. Ther., 1997, 281, 330-6.
81. Tarshis, M. S.; Weed, W. A., Jr. Am. Rev. Tuberc., 1953, 67, 391-5.
82. Wade, M. M.; Zhang, Y. J. Med. Microbiol., 2004, 53, 769-73.
83. Zhang, Y.; Permar, S.; Sun, Z. J. Med. Microbiol., 2002, 51, 42-9.
84. Mandell, G. L.; Petri, W. A. In Goodman and Gilman'sthe pharmacological basis of therapeutics, J.G. Hardman; L.E. Limbird; P.B. Molinoff; R.W. Ruddon; A. Goodman Gilman, eds.; McGraw-Hill: New York, NY, 1996, pp. 1161-2.
85. Scorpio, A.; Zhang, Y. Nat. Med., 1996, 2, 662-7.
86. Scorpio, A.; Lindholm-Levy, P.; Hoifets, L.; Gilman, R.; Siddiqi, S.; Cynamon, M.; Zhang, Y. Antimicrob. Agents Chemother., 1997, 41, 540-3.
87. Ernst Felder; Pitre, D. In Analytical Profiles of Drug Substances; Academic Press, 1983; Vol. 12, pp. 433-463.
88. Takayama, K.; Kilburn, J. O. Antimicrob. Agents Chemother., 1989, 33, 1493-9.
89. Teienti, A.; Philipp, W. J.; Sreevatsan, S.; Bernasconi, C.; Stockbauer, K. E.; Wieles, B.; Musser, J. M.; Jacobs, W. R., Jr. Nat. Med., 1997, 3, 567-70.
90. Sreevatsan, S.; Stockbauer, K. E.; Pan, X.; Kreiswirth, B. N.; Moghazeh, S. L.; Jacobs, W. R., Jr.; Telenti, A.; Musser, J. M. Antimicrob. Agents Chemother., 1997, 41, 1677-81.
91. Kanther, R. Antibiot. Chemother., 1970, 16, 203-14.
92. Girgis, E. H.; Gad, Z.; Maram, M. J. Pharm. Sci., 1974, 63, 1764-7.
93. Peets, E. A.; Sweeney, W. M.; Place, V. A.; Buyske, D. A. Am. Rev. Respir. Dis., 1965, 91, 51-8.
94. Mossa, J. S.; Taragan, A. H. U. K.; Hasan, M. M. A. In Analytical Profiles of Drug Substances; Academic Press: Burlington, MA, 1987; Vol. 16, pp. 507-552.
95. Douglas, J. G.; McLeod, M. J. Clin. Pharmacokinet., 1999, 37, 127-46.
96. William A. Petri, J. In Goodman and Gilman's The Pharmacological Basis of Therapeutics, Laurence L. Brunton;; John S. Lazo;; Keith L. Parke;, eds.; McGraw-Hill: New York, 2006, pp. 1203-24.
97. Mahmoud M.A Hassan; Ahmed I. Judo; Zubair, M. U. In Analytical Profiles of Drug Substances; Academic Press, 1981; Vol. 10, pp. 1-15.
98. Hughes, N. C.; Janezic, S. A.; McQueen, K. L.; Jewett, M. A.; Castranio, T.; Bell, D. A.; Grant, D. M. Pharmacogenetics, 1998, 8, 55-66.
99. Aranda, CP. In Tuberculosis, Rom, WN; Garay, SM, eds.; Lippincott-Raven: Philadelphia, 1997, pp. 811-6.
100. Mossa, J. S.; Taragan, A. H. U. K.; Hasan, M. M. A. In Analytical Profiles of Drug Substances; Academic press: Burlington, MA, 1987; Vol. 16, pp. 260-288.
101. DeBarber, A. E.; Mdluli, K.; Bosman, M.; Bekker, L. G.; Barry, C. E., 3rd. Proc. Natl. Acad. Sci. USA, 2000, 97, 9677-82.
102. Baulard, A. R.; Betts, J. C.; Engohang-Ndong, J.; Quan, S.; McAdam, R. A.; Brennan, P. J.; Locht, C.; Besra, G. S. J. Biol. Chem., 2000, 275, 28326-31.
103. Morlock, G., P.; Metchock, B.; Sikes, D.; Crawford, J. T.; Cooksey, R. C. Antimicrob. Agents Chemother., 2003, 47, 3799-805.
104. Jacobs, M. R. Drugs, 1995, 49 (Suppl, 2), 67-75.
105. Wishart, D. S.; Knox, C.; Guo, X. C.; Shrivastava, S.; Hassanali, M.; Stothard, P.; Chang, Z.; Woolsey, J. Nucleid Acids Res., 2006, 34, D668-72.
106. David, H. L.; Takayama, K.; Goldman, D. S. Am. Rev. Respir. Dis., 1969, 100, 579-81.
107. Strych, U.; Penland, R. L.; Jimenez, M.; Krause, K. L.; Benedik, M. J. FEMS Microbiol. Lett., 2001, 196, 93-8.
108. Lamb, J. W. In Analytical Profiles of Drug Substances; Academic Press, 1987; Vol. 1, pp. 54-64.
109. Strausbaugh, L. J.; Mandaleris, C. D.; Sande, M. A. J. Lab. Clin. Med., 1977, 89, 692-701.
110. Elliott, A. M.; Foster, S. D. Tuber. Lung Dis., 1996, 77, 27-9.
111. Burman, W. J.; Gallicano, K.; Peloquin, C. Clin. Pharmacokinet., 2001, 40, 327-41.
112. Mor, N.; Simon, B.; Mezo, N.; Heifets, L. Antimicrob. Agents Chemother., 1995, 39, 2073-7.
113. Reith, K.; Keung, A.; Toren, P. C.; Cheng, L.; Eller, M. G.; Weir, S. J. Drug Metab. Dispos., 1998, 26, 732-8.
114. Jarvis, B.; Lamb, H. M. Drugs, 1998, 56, 607-16.
115. Gillespie, S. H.; Billington, O. J. Antimicrob. Chemother., 1999, 44, 393-5.
116. Ji, B.; Lounis, N.; Maslo, C.; Truffot-Pernot, C.; Bonnafous, P.; Grosser, J. Antimicrob. Agents Chemother., 1998, 42, 2066-9.
117. Miyazaki, E.; Miyazaki, M.; Chen, J. M.; Chaisson, R. E.; Bishai, W. R. Antimicrob. Agents Chemother., 1999, 43, 85-9.
118. Pletz, M. W.; De Roux, A.; Roth, A.; Neumann, K. H.; Mauch, R.; Lode, H. Antimicrob. Agents Chemother., 2004, 48, 780-2.
119. U.S. Department of Health and Human Services Food & Drug Administration. Prescribing information: AVELOX: Silver Spring, MD 2004.
120. Tomioka, H. Curr. Pharm. Des., 2006, 12, 4047-70.
121. Paramasivan, C. N.; Sulochana, S.; Kubendiran, G.; Venkatesan, P.; Mitchison, D. A. Antimicrob. Agents Chemother., 2005, 49, 627-31.
122. Zhao, B. Y.; Pine, R.; Domagala, J.; Drlica, K. Antimicrob. Agents Chemother., 1999, 43, 661-6.
123. U.S. Department of Health and Human Services Food & Drug Administration. Prescribing information: TEQUIN: Silver Spring, MD 2004.
124. Alcala, L.; Ruiz-Serrano, M. J.; Perez-Fernandez Turegano, C.; Garcia De Viedma, D.; Diaz-Infantes, M.; Marin-Arriaza, M.; Bouza, E. Antimicrob. Agents Chemother., 2003, 47, 416-7.
125. von der Lippe, B.; Sandven, P.; Brubakk, O. J. Infect., 2006, 52, 92-6.
126. Fortun, J.; Martin-Davila, P.; Navas, E.; Perez-Elias, M. J.; Cobo, J., Tato, M.; De la Pedrosa, E. G.; Gomez-Mampaso, E.; Moreno, S. J. Antimicrob. Chemother., 2005, 56, 180-5.
127. Park, I. N.; Hong, S. B.; Oh, Y. M.; Kim, M. N.; Lim, C. M.; Lee, S. D.; Koh, Y.; Kim, W. S.; Kim, D. S.; Kim, W. D.; Shim, T. S. J. Antimicrob. Chemother., 2006, 58, 701-4.
128. U.S. Department of Health and Human Services Food & Drug Administration. Prescribing information: ZYVOX: Silver Spring, MD 2005.
129. Wayne, L. G.; Sramek, H. A. Antimicrob. Agents Chemother., 1994, 38, 2054-8.
130. Brooks, J. V.; Furney, S. K.; Orme, I. M. Antimicrob. Agents Chemother., 1999, 43, 1285-8.
131. Dhillon, J.; Allen, B. W.; Hu, Y. M.; Coates, A. R.; Mitchison, D. A. Int. J. Tuberc. Lung Dis., 1998, 2, 736-42.
132. Walsh, G. P.; Tan, E. V.; dela Cruz, E. C.; Abalos, R. M.; Villahermosa, L. G.; Young, L. J.; Cellona, R. V.; Nazareno, J. B.; Horwitz, M. A. Nat. Med., 1996, 2, 430-6.
133. U.S. National Institutes of Health ClinicalTrials.Gov. Metronidazole for Pulmonary Tuberculosis (South Korea), Dec 15, 2007: http://clinicaltrials.gov/ct/show/NCT00425113?order=1
134. U.S. Department of Health and Human Services Food & Drug Administration. Prescribing information: FLAGYL: Silver Spring, MD 2003.
135. Stover, C. K.; Warrener, P.; VanDevanter, D. R.; Sherman, D. R.; Arain, T. M.; Langhorne, M. H.; Anderson, S. W.; Towell, J. A.; Yuan, Y.; McMurray, D. N.; Kreiswirth, B. N.; Barry, C. E.; Baker, W. R. Nature, 2000, 405, 962-6.
136. AIDS Treat. News, 2000, 5-6.
137. Nuermberger, E.; Rosenthal, I.; Tyagi, S.; Williams, K. N.; Almeida, D.; Peloquin, C. A.; Bishai, W. R.; Grosset, J. H. Antimicrob. Agents Chemother., 2006, 50, 2621-5.
138. Ahmad, K. Lancet Infect. Dis., 2005, 5, 475.
139. Lillibridge, J. H.; Nywall, C. S.; Shawar, R. M.; Slattery, J. T. PA-824, a nitroimidazopyran antitubercular agent: Favorable pharmacokinetics parameters in mice after delivery in a novel oral formulation, Abstr. Intersci. Conf. Antimicrob. Agents Chemother. 1996.
140. Sasaki, H.; Haraguchi, Y.; Itotani, M.; Kuroda, H.; Hashizume, H.; Tomishige, T.; Kawasaki, M.; Matsumoto, M.; Komatsu, M.; Tsubouchi, H. J. Med. Chem., 2006, 49, 7854-60.
141. Matsumoto, M., Hashizume, H.; Tomishige, T.; Kawasaki, M.; Tsubouchi, H.: Sasaki, H.; Shimokawa, Y.; Komatsu, M. PLoS. Med., 2006, 3, e466.
142. Hittel, N.; kaisemetwork.org: London, 2006.
143. Koul, A.; Dendouga, N.; Vergauwen, K.; Molenberghs, B.; Vranckx, L.; Willebrords, R.; Ristic, Z.; Lill, H.; Dorange, I.; Guillemont, J.; Bald, D.; Andries, K. Nat. Chem. Biol., 2007, 3, 323-4.
144. Cole, S. T.; Alzari, P. M. Science, 2005, 307, 214-5.
145. World Health Organization. WHO Drug Information, 2006, 20.
146. Ibrahim, M.; Andries, K.; Lounis, N.; Chauffour, A.; Truffot-Pernot,.C.; Jarlier, V.; Veziris, N. Antimicrob. Agents Chemother., 2007, 51, 1011-5.
147. Mc Neely, D. F.; Cavaleri, M. TMC207 Oral Presentation, TBTC 17th Semi-Annual Group Meeting: San Diego, CA 2005.
148. U.S. National Institutes of Health ClinicalTrials.Gov. TMC207-TiDP13-C208: Anti-Bacterial Activity, Safety, and Tolerability of TMC207 in Patients With Multi-Drug Resistant Mycobacterium Tuberculosis (MDR-TB). 23 May 2007:http://clinicaltrials.gov/ct/show/ NCT00449644?order=1
149. Guengerich, F. P. Annu. Rev. Pharmacol. Toxicol., 1999, 39, 1-17.
150. Ginsberg, A, M.; Snigelman, M. Nat. Med., 2007, 13, 290-4.
151. Lee, R. E.; Protopopova, M.; Crooks, E.; Slayden, R. A.; Terrot, M.; Barry, C. E., 3rd. J. Comb. Chem., 2003, 5, 172-87.
152. Jia, L.; Tomaszewski, J. E.; Hanrahan, C.; Coward, L.; Noker, P.; Gorman, G.; Nikonenko, B.; Protopopova, M. Br. J. Pharmacol., 2005, 144, 80-7.
153. Nikonenko, B. V.; Protopopova, M.; Samala, R.; Einck, L.; Nacy, C. A. Antimicrob. Agents Chemother., 2007, 51, 1563-5.
154. Jia, L.; Noker, P. E.; Coward, L.; Gorman, G. S.; Protopopova, M.; Tomaszewski, J. E. Br. J. Pharmacol., 2006, 147, 476-85.
155. Craig, W. A. Clin. Infect. Dis,, 1998, 26, 1-10; quiz 11-2.
156. Wright, D. H.; Brown, G. H.; Peterson, M. L.; Rotschafer, J. C. J. Antimicrob. Chemother., 2000, 46, 669-83.
157. Jayaram, R.; Shandil, R. K.; Gaonkar, S.; Kaur, P.; Suresh, B. L.; Mahesh, B. N.; Jayashree, R.: Nandi, V; Bharath, S.; Kantharaj, E.; Balasubramanian, V. Antimicrob. Agents Chemother., 2004, 48, 2951-7.
158. Jayaram, R.; Gaonkar. S.; Kaur, P.; Suresh, B. L.; Mahesh, B. N.; Jayashree, R.; Nandi, V; Bharat, S.; Shandil, R. K.; Kantharaj, E.; Balasubramanian, V. Antimicrob. Agents Chemother., 2003, 47, 2118-24.
159. Shandil, R. K.; Jayaram, R.; Kaur, P.; Gaonkar, S.; Suresh, B. L.; Mahesh, B. N.; Jayashree, R.; Nandi, V.; Bharath, S., Balasubramanian, V. Antimicrob. Agents Chemother., 2007, 51, 576-82.
160. Oliveira, J. S.; Pereira, J. H.; Canduri, F.; Rodrigues, N. C.; de Souza, O. N.; de Azevedo, W. F., Jr.; Basso, L. A.; Santos, D. S. J. Mol. Biol., 2006, 359, 646-66.
161. Kondo, J.; Francois, B.; Russell, R. J.; Murray, J. B.; Westhof, E. Biochimie, 2006, 88, 1027-31.
162. Sampathkumar, P.; Turley, S.; Ulmer, J. E.; Rhie, H. G.; Sibley, C. H.; Hol, W. G. J. Mol. Biol., 2005, 352, 1091-104.
163. Israili, Z. H.; Rogers, C. M.; el-Attar, H. J. Clin. Pharmacol., 1987, 27, 78-83.
164. Bergogne-Berezin, E. Clin. Pharmacokinet., 2002, 41, 741-50.
165. Berning, S. E. Drugs, 2001, 61, 9-18.
166. Tomioka, H.; Saito, H.; Sato, K. Antimicrob. Agents Chemother., 1993, 37, 1259-63.
167. Balfour, J. A.; Lamb, H. M. Drugs, 2000, 59, 115-39.
168. Diekema, D. I.; Jones, R. N. Drugs, 2000, 59, 7-16.
169. U.S. National Institutes of Health National Institute for Allergy and Infectious Diseases. HIV/OI Therapeutics Database, 25 May, 2007:hTtp://chemdb2.niaid.nih.gov/struct_search/all/ url_search.asp?aids_no=070944
170. Cruciani, G.; Pastor, M.; Guba, W. Eur. J. Pharm. Sci., 2000, 11 Suppl 2, S29-39.
171. Nuermberger, E.; Grosset, J. Eur. J. Clin. Mcrobiol. Infect. Dis., 2004, 23, 243-55.